Adrienne Boudreau

Sometimes, counsel and their clients litigating in Ontario are faced with motions from the other side that are more tactical than substantive or are just “overkill” given the nature of the action.

The Canadian Competition Bureau is taking a “keen interest” in patent litigation settlements between brand and generic drug manufacturers.  It has taken the view that such settlements could actually be anti-competitive, competitor collaborations in breach of the Competition Act. Pharmaceutical regulation in Canada In Canada pharmaceutical medicines are federally regulated.  Health Canada regulates both “innovator” […]

Price-fixing conspiracies harm retailers and consumers by forcing them to pay unlawful overcharges on products and services.  The Competition Act, which regulates business conduct throughout Canada, allows retailers and consumers to recover any losses that they suffered as a result of such unlawful conspiracies.  Without this important remedy, retailers and consumers could not obtain compensation […]